Screening Women in Jails for Chlamydial and Gonococcal Infection Using Urine Tests

Mertz, Kristen J.; Schwebke, Jane R.; Gaydos, Charlotte A.; Beidinger, Heidi; Tulloch, Scott; Levine, William C.

doi:10.1097/00007435-200205000-00004

Cited by 70 publications

(38 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…9 The prevalence of STIs, such as Chlamydia infection, gonorrhea, and trichomoniasis, as well as hepatitis B and C is also several times higher among incarcerated women. [10][11][12][13] Although the BOP recommends routine screening for syphilis and risk-based screening for Chlamydia and hepatitis B and C in prison, 8 the opportunity to screen and vaccinate is often missed, particularly in the jail setting. 14,15 Given the overlap of injection drug use (IDU) and high-risk sexual encounters, the prevalence of HIV is also higher among incarcerated women than in the general population.…”

mentioning

confidence: 99%

Preventive Healthcare for Underserved Women: Results of a Prison Survey

Nijhawan

Salloway

Nunn

et al. 2010

Journal of Women's Health

View full text Add to dashboard Cite

Objectives: We sought to determine the preventive healthcare needs of incarcerated women in the following areas: cervical cancer and breast cancer screening, sexually transmitted infection (STI) screening, hepatitis screening and vaccination, and smoking cessation. Methods: A cross-sectional interview survey of a random sample of 100 incarcerated women at the Rhode Island Department of Corrections (RIDOC) in Cranston, Rhode Island, was conducted. Results: Participants were 62% white, 11% African American, 13% Hispanic, and 14% of mixed race. Mean age was 35 years. Of those surveyed, 67% reported having had a Papanicolou (Pap) smear in the past year, the strongest predictor of which was having received a Pap smear while incarcerated. Of the inmates >40 years old, 58% reported having had a mammogram in the past 2 years. The majority (88%) reported testing for STIs in the past, and 39% desired testing during their current incarceration. As for hepatitis C, 70% had been tested previously and 37% of those reported testing positive. Hispanics were less likely than whites to have been tested for hepatitis C (OR 0.1). Over half (54%) of the women who reported testing positive for hepatitis C also reported having completed the hepatitis A and B vaccine series. Among smokers (80% of all survey participants), 61% were interested in quitting. Those who had been incarcerated multiple times were less likely to want to quit smoking (OR 0.1). Conclusions: Incarceration presents a unique opportunity to provide preventive healthcare to high-risk, medically underserved women.

show abstract

mentioning

confidence: 99%

Preventive Healthcare for Underserved Women: Results of a Prison Survey

Nijhawan

Salloway

Nunn

et al. 2010

Journal of Women's Health

View full text Add to dashboard Cite

show abstract

“…[3][4][5][6][7][8] During incarceration, inmates face the risk of forming new and sometimes coercive sex partnerships with individuals at high risk of infection. 9 Furthermore, incarceration is a disruptive life event that destabilizes intimate partnerships.…”

mentioning

confidence: 99%

Incarceration and High-Risk Sex Partnerships among Men in the United States

et al. 2009

View full text Add to dashboard Cite

“…When designing any clinical research study, the foremost difficulty is gaining access to detained women. This limitation has been well documented and is due to a variety of factors including inmate release to the community before contact can be made, restrictions on inmate movement, inmate medical illness, and court/legal proceedings (Beltrami, Cohen, Hamrick, & Farley, 1997;Cohen et al, 2005;Grinstead, Zack, & Faigeles, 1999;Mertz et al, 2002).…”

mentioning

confidence: 99%